Lamotrigine in the adult-onset epilepsy: Efficacy and long-term safety;Lamotrigina en las epilepsias del adulto: Eficacia y seguridad a largo plazo

Neurologia

Volumn 17, Issue 3, 2002, Pages 136-142

  Alegre, M ^a   Iriarte, J ^a   Schlumberger, E ^a   Urrestarazu, E ^a   Lazaro D ^a   Viteri, C ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Efficacy; Epilepsy; Lamotrigine; Safety

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE;

ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; EPILEPSY; FOLLOW UP; HUMAN; ONSET AGE; PATIENT CARE; RETROSPECTIVE STUDY; SEIZURE; TIME; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ANTICONVULSANTS; EPILEPSY; HUMANS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZINES;

EID: 0036520764     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. New antiepileptic drugs: A systematic review of their efficacy and tolerability
2. Clinical administration of new antiepileptic drugs: An overview of safety and efficacy
3. New antiepileptic drugs - An explosion of activity
4. An overview of the efficacy and tolerability of new antiepileptic drugs
5. An audit of the new antiepileptic drugs in clinical neurological practice
6. New antiepileptic drugs
7. Overview of the safety of newer antiepileptic drugs
8. Lamotrigine in treatment of 120 children with epilepsy
9. Lamotrigine treatment in childhood drug resistant epilepsy
10. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy
11. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy
12. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures
13. Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy
14. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures
15. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures
16. Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, double-blind, cross-over trial
17. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures
18. Lamotrigine
19. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy
20. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: A randomized, double-blind, crossover study
21. Safety review of adult clinical trial experience with lamotrigine
22. The long-term use of Gabapentin, Lamotrigine and Vigabatrin in patients with chronic epilepsy
23. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome)
24. A survey comparing lamotrigine and vigabatrin in everyday clinical practice
25. Impact of lamotrigine on patients with refractory epilepsy: The Leicester experience
26. Proposal for revised clinical and electroencephalographic classification of epileptic seizures
27. Proposal for revised classification of epilepsies and epileptic syndromes
28. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy
29. Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy
30. The role of lamotrigine in the treatment of epilepsy
31. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy
32. Lamotrigine: Clinical experience in 200 patients with epilepsy with follow-up to four years
33. An active-control trial of lamotrigine monotherapy for partial seizures
34. Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures
35. Adding lamotrigine to the treatment of epilepsy which is difficult to control
36. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
37. Lamotrigine for the treatment of epilepsy in childhood
38. Lamotrigine: Clinical experience in 93 patients with epilepsy
39. Lamotrigina en epilepsia parcial y generalizada refractarias
40. Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy
41. Vigabatrin visual toxicity evolution and dose dependence
42. Safety of long-term lamotrigine in epilepsy
43. Human safety of lamotrigine
44. Lamotrigine associated with insomnia
45. Lamotrigine-induced carbamazepine toxicity: An interaction with carbamazepine-10,11-epoxide
46. Lamotrigine and therapeutic drug monitoring: Retrospective survey following the introduction of a routine service
47. Routine use of lamotrigine, a new anti-epileptic medication, and the value of measuring its blood levels
48. Serum concentrations of lamotrigine in epileptic patients: The influence of dose and comedication
49. Concentration-effect and concentration-toxicity relations with lamotrigine: A prospective study